search
investors
MEI Pharma is focused on the clinical development of novel therapies for the treatment of cancer. We were incorporated in Delaware in December 2000 and began trading on Nasdaq in December 2003. Dr. Daniel Gold was appointed President & CEO in April 2010 and we established our headquarters in San Diego shortly thereafter. In December 2012, we completed a $27.5 million private placement in a financing led by new investors Vivo Ventures and New Leaf Venture Partners, followed by a $15.2 million registered offering in April 2013. Our common stock is traded on the Nasdaq Capital Market under the symbol MEIP.
financial information
Click here for our most recent filings with the U.S. Securities and Exchange Commission.
IRS Form 8937 - Rights Offering
IRS Form 8937 - Reverse Split
XBRL Files
[Form 10-Q for Period Ended 9/30/11]
[Form 10-Q for Period Ended 12/31/11]
[Form 10-Q for Period Ended 3/31/12]
[Form 10-K for Period Ended 6/30/12]
[Form 10-Q for Period Ended 9/30/12]
[Form 10-Q for Period Ended 12/31/12]
[Form 10-Q for Period Ended 3/31/13]
corporate governance
Code of Business Conduct and Ethics
Audit Committee Charter
Compensation Committee Charter
Nominating & Governance Committee Charter
annual report
Click here for our 2012 Annual Report
analyst coverage
Roth Capital Partners
Joseph Pantginis, Ph.D.
(646) 358-1907
jpantginis@roth.com
Raluca Pancratov, Ph.D.
(646) 358-1914
rpancratov@roth.com
Stifel
Brian Klein, MD
(212) 271-3807
kleinb@stifel.com
Please note that any opinions, estimates or forecasts made by analysts are theirs alone and do not represent those of MEI Pharma or its management. MEI Pharma does not by reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
stock info
Click here for our current stock quote.
events & webcasts
April 30, 2013
Needham Healthcare Conference
[ webcast + slides ]
March 26, 2013
Annual Meeting of Stockholders
[ webcast ]
March 19, 2013
ROTH Conference
[ webcast + slides ]
March 6, 2013
Cowen and Company Health Care Conference
[ webcast + slides ]
contact
Pete De Spain
Sr. Director, Investor Relations
& Corporate Communications
MEI Pharma, Inc.
(858) 369-7199
investor@meipharma.com